Roche Holding AG (OTCMKTS:RHHBY) Receives Consensus Rating of "Moderate Buy" from Brokerages

Key Points

• Roche Holding AG has received a consensus rating of "Moderate Buy" from seven ratings firms, with one sell rating, three hold ratings, one buy rating, and two strong buy ratings.
• Shares of Roche are currently trading at $40.77, with a 1-year low of $34.10 and a 1-year high of $44.31.
• Institutional investors, including GAMMA Investing LLC and Boston Common Asset Management LLC, have significantly increased their stakes in Roche, indicating strong interest from the investment community.

Shares of Roche Holding AG (OTCMKTS:RHHBY - Get Free Report) have been assigned an average recommendation of "Moderate Buy" from the seven research firms that are currently covering the company, MarketBeat.com reports. One analyst has rated the stock with a sell recommendation, three have given a hold recommendation, one has issued a buy recommendation and two have assigned a strong buy recommendation to the company.

Hedge Funds Weigh In On Roche

A number of large investors have recently modified their holdings of RHHBY. Altrius Capital Management Inc grew its holdings in shares of Roche by 3.6% in the 1st quarter. Altrius Capital Management Inc now owns 189,993 shares of the company's stock worth $7,818,000 after acquiring an additional 6,545 shares during the period. Everett Harris & Co. CA acquired a new position in Roche in the first quarter worth about $445,000. Bard Financial Services Inc. boosted its stake in Roche by 25.3% in the first quarter. Bard Financial Services Inc. now owns 138,900 shares of the company's stock valued at $5,716,000 after acquiring an additional 28,050 shares during the period. Rhumbline Advisers raised its holdings in Roche by 7.4% during the first quarter. Rhumbline Advisers now owns 107,252 shares of the company's stock worth $4,413,000 after purchasing an additional 7,374 shares in the last quarter. Finally, Riverbridge Partners LLC grew its position in Roche by 6.7% during the 1st quarter. Riverbridge Partners LLC now owns 37,826 shares of the company's stock worth $1,557,000 after purchasing an additional 2,381 shares in the last quarter.

Roche Price Performance

RHHBY traded up $1.03 on Tuesday, hitting $42.05. 2,664,399 shares of the company were exchanged, compared to its average volume of 1,432,268. The firm has a 50-day moving average price of $40.14 and a two-hundred day moving average price of $40.32. Roche has a twelve month low of $34.10 and a twelve month high of $44.31. The company has a current ratio of 1.48, a quick ratio of 1.20 and a debt-to-equity ratio of 0.85.

About Roche

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.